Article Text

Download PDFPDF

Acupuncture treatment for knee osteoarthritis with sensitive points: protocol for a multicentre randomised controlled trial
  1. Li Tang1,
  2. Pengli Jia1,
  3. Ling Zhao2,
  4. Deying Kang1,
  5. Yanan Luo2,
  6. Jiali Liu1,
  7. Ling Li1,
  8. Hui Zheng2,
  9. Ying Li2,
  10. Ning Li3,
  11. Gordon Guyatt4,
  12. Xin Sun1
  1. 1 Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China
  2. 2 Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China
  3. 3 Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China
  4. 4 Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada
  1. Correspondence to Dr Xin Sun; sunx79{at}hotmail.com

Abstract

Introduction There is a lack of curative medical treatment for patients with knee osteoarthritis (KOA). Acupuncture represents an important alternative therapy. According to the theory of traditional Chinese medicine and preliminary clinical evidence, the patients’ acupoints and tender points may become sensitised when the body suffers from a disease state; stimulation of such sensitive points could lead to a disease improvement. It is thus hypothesised that acupuncture at highly sensitised points on patients with KOA would achieve better treatment outcomes than acupuncture at low/non-sensitised points. Previously, we conducted a pilot trial to prove the feasibility of further investigation.

Methods and analysis A three-arm, parallel, multicentre randomised controlled trial of 666 patients will be conducted at four hospitals of China. Eligible patients with KOA who consent to participate will be randomly assigned to a high-sensitisation group (patients receive acupuncture treatment at high-sensitive points), a low/non-sensitisation group (patients receive acupuncture treatment at low/non-sensitive points) or a waiting-list group (patients receive standard acupuncture treatment after the study is concluded) via a central randomisation system using 1:1:1 ratio. The primary outcome is the change of Western Ontario and McMaster Universities Osteoarthritis Index total score from baseline to 16 weeks. Outcome assessors and data analysts will be blinded and participants will be asked not to reveal their allocation to assessors. The outcome analyses will be performed both on the intention-to-treat and per-protocol population. The primary analyses will test if acupuncture at highly sensitised points would achieve statistically better treatment outcomes than acupuncture at low/non-sensitised points and no acupuncture (ie, waiting list), respectively. A small number of prespecified subgroup analyses will be conducted.

Ethics and dissemination Ethics approval has been granted by the Bioethics Subcommittee of West China Hospital, Sichuan University: 2017 (Number 228). Results will be expected to be published in peer-reviewed journals.

Trial registration number NCT03299439.

  • acupuncture
  • knee osteoarthritis
  • randomised controlled trial
  • sensitised points

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • LT and PJ contributed equally.

  • Contributors XS conceived the study and acquired the funding. XS, GG, LT, PJ, LZ, DK, YL, JL, LL, HZ, YL and NL participated in improving the study design. LT and PJ drafted the manuscript. XS, GG, LT, PJ, LZ, DK, YL, JL, LL, HZ, YL and NL critically revised the manuscript. All authors read and approved the final manuscript. XS is the guarantor.

  • Funding This study is funded by the National Natural Science Foundation of China (grant number 81590955), and XS is supported by the ’Thousand Youth Talents Plan' of China (grant number D1024002).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Ethics approval has been granted by the Bioethics Subcommittee of West China Hospital, Sichuan University: 2017 (Number 228).

  • Provenance and peer review Not commissioned; externally peer reviewed.